Guillaume Moulis

6.0k total citations · 1 hit paper
129 papers, 2.6k citations indexed

About

Guillaume Moulis is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Guillaume Moulis has authored 129 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Hematology, 26 papers in Surgery and 26 papers in Genetics. Recurrent topics in Guillaume Moulis's work include Platelet Disorders and Treatments (58 papers), Blood groups and transfusion (48 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (20 papers). Guillaume Moulis is often cited by papers focused on Platelet Disorders and Treatments (58 papers), Blood groups and transfusion (48 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (20 papers). Guillaume Moulis collaborates with scholars based in France, United States and Denmark. Guillaume Moulis's co-authors include Maryse Lapeyre‐Mestre, L. Sailler, Jean‐Louis Montastruc, Aurore Palmaro, Laurent Balardy, Bruno Vellas, Martin Michaud, Caroline Peyrot, Matteo Cesari and Fati Nourhashémi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Guillaume Moulis

113 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Proinflammatory Cytokines, Aging, and Age-Related Diseases

2013 808 citations Martin Michaud, Laurent Balardy et al. Journal of the American Medical Directors Association profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guillaume Moulis France	23	804	377	341	336	325	129	2.6k
Ken Tsuchiya Japan	32	466 0.6×	353 0.9×	697 2.0×	263 0.8×	430 1.3×	241	4.2k
Antoni Castro Spain	25	355 0.4×	227 0.6×	285 0.8×	177 0.5×	85 0.3×	108	2.2k
Stacey S. Cofield United States	31	253 0.3×	595 1.6×	419 1.2×	166 0.5×	734 2.3×	81	3.2k
Antonios Stavropoulos‐Kalinoglou United Kingdom	32	825 1.0×	365 1.0×	185 0.5×	98 0.3×	304 0.9×	66	3.0k
Helmuth Haslacher Austria	26	339 0.4×	167 0.4×	375 1.1×	114 0.3×	109 0.3×	139	2.6k
Pierre‐Yves Scarabin France	39	804 1.0×	152 0.4×	407 1.2×	145 0.4×	636 2.0×	88	5.6k
Christopher J. Swearingen United States	28	351 0.4×	208 0.6×	450 1.3×	88 0.3×	240 0.7×	110	3.1k
M. Sund Germany	20	401 0.5×	381 1.0×	563 1.7×	284 0.8×	205 0.6×	34	2.9k
Veli Kairisto Finland	22	379 0.5×	374 1.0×	168 0.5×	253 0.8×	89 0.3×	48	1.7k
Andrew P. Yu United States	33	254 0.3×	302 0.8×	673 2.0×	117 0.3×	164 0.5×	80	3.7k

Countries citing papers authored by Guillaume Moulis

Since Specialization

Citations

This map shows the geographic impact of Guillaume Moulis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillaume Moulis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillaume Moulis more than expected).

Fields of papers citing papers by Guillaume Moulis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillaume Moulis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillaume Moulis. The network helps show where Guillaume Moulis may publish in the future.

Co-authorship network of co-authors of Guillaume Moulis

This figure shows the co-authorship network connecting the top 25 collaborators of Guillaume Moulis. A scholar is included among the top collaborators of Guillaume Moulis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillaume Moulis. Guillaume Moulis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moulis, Guillaume, Sylvain Audia, Louis Terriou, et al.. (2025). Efficacy and safety of dapsone in adult primary immune thrombocytopenia. Blood Advances. 9(8). 1976–1983.

Mahévas, T., Guillaume Moulis, Patricia Senet, et al.. (2025). Treatment strategies and outcomes in adult relapsing or refractory cutaneous IgA Vasculitis: A multicenter retrospective cohort study. Seminars in Arthritis and Rheumatism. 75. 152870–152870.

Perkins, Géraldine, et al.. (2025). Thrombopénie immunologique induite par chimiothérapie : un coupable peut en cacher un autre. La Revue de Médecine Interne. 46(6). 313–319.

Moulis, Guillaume, Nathalie Aladjidi, & Bertrand Godeau. (2023). Clinical significance of antinuclear antibodies in primary immune thrombocytopenia. British Journal of Haematology. 203(1). 131–135. 4 indexed citations

Schifferli, Alexandra, et al.. (2023). Chronic refractory immune thrombocytopenia in adolescents and young adults. British Journal of Haematology. 203(1). 36–42. 1 indexed citations

Lafaurie, Margaux, et al.. (2023). Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a nationwide cohort study. Blood Advances. 8(3). 817–826. 10 indexed citations

Lafaurie, Margaux, Emmanuel Treiner, Ondine Walter, et al.. (2023). Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases. International Immunopharmacology. 120. 110342–110342. 3 indexed citations

Moulis, Guillaume & Lamya Garabet. (2023). Markers of refractory primary immune thrombocytopenia. British Journal of Haematology. 203(1). 112–118. 2 indexed citations

Hansen, Dennis Lund, Margaux Lafaurie, Sören Möller, et al.. (2023). Primary autoimmune haemolytic anaemia is associated with increased risk of ischaemic stroke: A binational cohort study from Denmark and France. British Journal of Haematology. 204(3). 1072–1081. 1 indexed citations

10.

Walter, Ondine, et al.. (2021). Validation of Discharge Diagnosis of Sickle Cell Disease Vaso-Occlusive Episodes in the French Hospital Electronic Database. Clinical Epidemiology. Volume 13. 717–720. 4 indexed citations

11.

Walter, Ondine, Pierre Cougoul, Pablo Bartolucci, et al.. (2021). Risk of Hospitalization for Vaso-Occlusive Episode in Patients with Sickle Cell Disease after out-Patient Exposure to Systemic Corticosteroids. Blood. 138(Supplement 1). 2048–2048.

12.

Moulis, Guillaume, Christian Fynbo Christiansen, Bianka Darvalics, Ina Trolle Andersen, & Mette Nørgaard. (2020). <p>Platelet Count within the Normal Range at Hospital Admission is Associated with Mortality in Patients with Community-Acquired Pneumonia</p>. Clinical Epidemiology. Volume 12. 711–716. 3 indexed citations

13.

Moulis, Guillaume, Christian Fynbo Christiansen, Bianka Darvalics, et al.. (2020). Platelet counts of adults upon acute hospital admission to internal medicine units are a predictor of mortality. Annals of Hematology. 99(3). 451–457. 2 indexed citations

14.

Moulis, Guillaume, et al.. (2020). Platelet Count within the Normal Range at Hospital Admission is Associated with Mortality in Patients with Community-Acquired Pneumonia. SHILAP Revista de lepidopterología. 1 indexed citations

15.

Ekstrand, Charlotta, Marie Linder, Bérangère Baricault, et al.. (2019). Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia – Results from two nationwide cohorts. Thrombosis Research. 178. 124–131. 24 indexed citations

16.

Moulis, Guillaume, Haleh Bagheri, L. Sailler, et al.. (2014). Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009–2013 French PharmacoVigilance assessment. European Journal of Internal Medicine. 25(8). 777–780. 23 indexed citations

17.

Michaud, Martin, Laurent Balardy, Guillaume Moulis, et al.. (2013). Proinflammatory Cytokines, Aging, and Age-Related Diseases. Journal of the American Medical Directors Association. 14(12). 877–882. 808 indexed citations breakdown →

18.

Dupouy, Julie, Guillaume Moulis, M. Tubéry, et al.. (2013). Which Adverse Events Are Related to Health Care during Hospitalization in Elderly Inpatients?. International Journal of Medical Sciences. 10(9). 1224–1230. 9 indexed citations

19.

Moulis, Guillaume, Agnès Sommet, Johana Béné, et al.. (2012). Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses. PLoS ONE. 7(11). e48991–e48991. 63 indexed citations

20.

Moulis, Guillaume, et al.. (2011). Drug-induced immune thrombocytopenia: A descriptive survey in the French PharmacoVigilance database. Platelets. 23(6). 490–494. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact